These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8864999)
21. Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients. Kakkar A; Suri V; Jha P; Srivastava A; Sharma V; Pathak P; Sharma MC; Sharma MS; Kale SS; Chosdol K; Phalak M; Sarkar C Neurol India; 2011; 59(2):254-61. PubMed ID: 21483128 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas. Terada K; Tamiya T; Daido S; Kambara H; Tanaka H; Ono Y; Matsumoto K; Ito S; Ouchida M; Ohmoto T; Shimizu K J Neurooncol; 2002 Jun; 58(2):107-14. PubMed ID: 12164681 [TBL] [Abstract][Full Text] [Related]
23. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors. Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070 [TBL] [Abstract][Full Text] [Related]
24. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas. Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927 [TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours. Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974 [TBL] [Abstract][Full Text] [Related]
26. Molecular genetic alterations in glioblastomas with oligodendroglial component. Kraus JA; Lamszus K; Glesmann N; Beck M; Wolter M; Sabel M; Krex D; Klockgether T; Reifenberger G; Schlegel U Acta Neuropathol; 2001 Apr; 101(4):311-20. PubMed ID: 11355302 [TBL] [Abstract][Full Text] [Related]
27. Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors. Maruno M; Yoshimine T; Muhammad AK; Ninomiya H; Kato A; Hayakawa T Cancer Lett; 1999 Jan; 135(1):61-6. PubMed ID: 10077222 [TBL] [Abstract][Full Text] [Related]
28. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India. Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227 [TBL] [Abstract][Full Text] [Related]
29. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Jeng YM; Hsu HC Int J Cancer; 2003 Jul; 105(5):625-9. PubMed ID: 12740910 [TBL] [Abstract][Full Text] [Related]
30. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis]. Xu XF; Tang PZ; Cheng SJ Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701 [TBL] [Abstract][Full Text] [Related]
31. Loss of 14q chromosome in oligodendroglial and astrocytic tumors. Dichamp C; Taillibert S; Aguirre-Cruz L; Lejeune J; Marie Y; Kujas M; Delattre JY; Hoang-Xuan K; Sanson M J Neurooncol; 2004 May; 67(3):281-5. PubMed ID: 15164983 [TBL] [Abstract][Full Text] [Related]
32. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Ohgaki H; Kleihues P J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639 [TBL] [Abstract][Full Text] [Related]
34. Genetic alterations in pediatric high-grade astrocytomas. Cheng Y; Ng HK; Zhang SF; Ding M; Pang JC; Zheng J; Poon WS Hum Pathol; 1999 Nov; 30(11):1284-90. PubMed ID: 10571506 [TBL] [Abstract][Full Text] [Related]
35. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression. Oskam NT; Bijleveld EH; Hulsebos TJ Int J Cancer; 2000 Feb; 85(3):336-9. PubMed ID: 10652423 [TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Fults D; Tippets RH; Thomas GA; Nakamura Y; White R Cancer Res; 1989 Dec; 49(23):6572-7. PubMed ID: 2573417 [TBL] [Abstract][Full Text] [Related]
37. Amplification of the anonymous marker D17S67 in malignant astrocytomas. Bijlsma EK; Leenstra S; Westerveld A; Bosch DA; Hulsebos TJ Genes Chromosomes Cancer; 1994 Feb; 9(2):148-52. PubMed ID: 7513547 [TBL] [Abstract][Full Text] [Related]
38. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168 [TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma. Zainuddin N; Jaafart H; Isa MN; Abdullah JM Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064 [TBL] [Abstract][Full Text] [Related]